An investigator is evaluating a new transdermal hormonal contraceptive for its association with venous thromboembolism (VTE) in women of reproductive age. Initial overall analysis reveals that women using the transdermal patch have a relative risk (RR) of 4.2 for developing VTE compared to non-users. The research team suspects that an underlying genetic predisposition might alter this relationship. They subsequently divide the cohort based on the presence or absence of the prothrombin G20210A mutation. Among participants who carry the mutation, the relative risk of VTE in transdermal patch users compared to non-users is 15.5. Among participants who do not carry the mutation, the relative risk is 2.1. Both stratified findings are statistically significant. Which of the following epidemiological concepts best describes the role of the prothrombin G20210A mutation in this scenario?
- Effect modificationAnswer
- BConfounding
- CSelection bias
- DRecall bias
- ELead-time bias